Comparative study between NAD(P)H:quinone Oxidoreductase 1 (NQO1) and Heme Oxygenase-1 (HO-1) enzymes induced by an equal dose of different classes of dietary chemicals in mice liver
Article Sidebar
-
NQO1, Heme oxygenase-1, Dietary chemicals, Gene expression, Mouse liver
Abstract
Objective: Dietary chemicals, which are generally found in vegetables, fruits and spices, have been reported to protect against cancer based on their ability to activate endogenous defenses by inducing the expression of phase II detoxification and antioxidant enzymes such as NAD(P)H:quinone Oxidoreductase 1 (NQO1) and Heme Oxygenase-1 (HO-1). The objective of this study is to compare the potency of induction of NQO1 and HO-1 genes, and their protein products in mice livers following administration of equal doses (50 mg/kg) of five different dietary chemicals (sulforaphane, quercetin, curcumin, butylated hydroxyanisole, indole-3-carbinol). Methods: Adult male ICR white mice were divided into 8 groups (n=6 per group) i.e. normal control, sulforaphane, quercetin, curcumin, butylated hydroxyanisole, indole-3-carbinol, vehicle 1 control and vehicle 2 control groups. The chemicals were administered intraperitoneally for 14 days at a dose of 50 mg/kg body weight. At day 15, the mice were sacrificed and their livers isolated. Total RNA was extracted, reverse transcribed and subjected to quantitative real-time PCR to detect NQO1 and HO-1 gene expression. Western blots were also performed to determine NQO1 and HO-1 protein expression. Results: The comparison between NQO1 and HO-1 gene expression showed that equal doses (50mg/kg) of dietary chemicals induced HO-1 gene expression more potently than NQO1. Meanwhile, they induced NQO1 and HO-1 protein with the similar potency. Conclusions: Equal doses (50mg/kg) of sulforaphane, indole 3 carbinol, butylated hydroxyanisole and curcumin induced HO-1 gene expression more potently than NQO1 while they induced NQO1 and HO-1 protein expression with the similar potency.
Full text article
References
[1] Eussen, S. R., et al. (2011). Functional foods and dietary supplements: Products at the interface between pharma and nutrition. European Journal of Pharmacology, 668(1), S2–S9.
[2] Lee, J. H., et al. (2013). Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacology & Therapeutics, 137(2), 153–171.
[3] Hosseini, A., & Ghorbani, A. (2015). Cancer therapy with phytochemicals: Evidence from clinical studies. Avicenna Journal of Phytomedicine, 5(2), 84.
[4] Liu, H., et al. (2015). Fruit and vegetable consumption and risk of bladder cancer: An updated meta-analysis of observational studies. European Journal of Cancer Prevention, 24(6), 508–516.
[5] Khan, N., & Mukhtar, H. (2015). Dietary agents for prevention and treatment of lung cancer. Cancer Letters, 359(2), 155–164.
[6] Núñez-Sánchez, M. A., et al. (2015). Dietary phenolics against colorectal cancer—From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs. Molecular Nutrition & Food Research, 59(7), 1274–1291.
[7] Abbas, Z. K., et al. (2015). Phytochemical, antioxidant and mineral composition of hydroalcoholic extract of chicory (Cichorium intybus L.) leaves. Saudi Journal of Biological Sciences, 22(3), 322–326.
[8] Abuajah, C. I., Ogbonna, A. C., & Osuji, C. M. (2015). Functional components and medicinal properties of food: A review. Journal of Food Science and Technology, 52(5), 2522–2529.
[9] Wattenberg, L. W. (1978). Inhibitors of chemical carcinogenesis. Advances in Cancer Research, 26, 197–226.
[10] Keum, Y.-S. (2012). Regulation of Nrf2-mediated phase II detoxification and anti-oxidant genes. Biomolecules & Therapeutics, 20(2), 144.
[11] Eggler, A. L., Gay, K. A., & Mesecar, A. D. (2008). Molecular mechanisms of natural products in chemoprevention: Induction of cytoprotective enzymes by Nrf2. Molecular Nutrition & Food Research, 52(S1), S84–S94.
[12] Kim, J., et al. (2017). Capillarisin augments anti-oxidative and anti-inflammatory responses by activating Nrf2/HO-1 signaling. Neurochemistry International, 105, 11–20.
[13] Kitteringham, N. R., et al. (2010). Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. Journal of Proteomics, 73(8), 1612–1631.
[14] Abdullah, A., et al. (2012). Analysis of the role of Nrf2 in the expression of liver proteins in mice using two-dimensional gel-based proteomics. Pharmacological Reports, 64(3), 680–697.
[15] Itoh, K., et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications, 236(2), 313–322.
[16] He, C. H., et al. (2001). Identification of activating transcription factor 4 (ATF4) as a Nrf2 interacting protein: Implication for heme oxygenase-1 gene regulation. Journal of Biological Chemistry.
[17] Jaiswal, A. K. (2000). Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radical Biology and Medicine, 29(3–4), 254–262.
[18] Jana, S., & Mandlekar, S. (2009). Role of phase II drug metabolizing enzymes in cancer chemoprevention. Current Drug Metabolism, 10(6), 595–616.
[19] Roubalová, L., et al. (2017). Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells. Fitoterapia, 119, 115–120.
[20] Hervera, A., et al. (2013). Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of μ-opioid receptors during neuropathic pain. Anesthesiology: The Journal of the American Society of Anesthesiologists, 118(5), 1180–1197.
[21] Young Bang, S., et al. (2012). Achyranthes japonica exhibits anti-inflammatory effect via NF-κB suppression and HO-1 induction in macrophages. Journal of Ethnopharmacology, 144(1), 109–117.
[22] Calabrese, V., et al. (2010). Cellular stress responses, the hormesis paradigm, and vitagenes: Novel targets for therapeutic intervention in neurodegenerative disorders. Antioxidants & Redox Signaling, 13(11), 1763–1811.
[23] Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods, 25(4), 402–408.
[24] Kong, L., et al. (2007). Delay of photoreceptor degeneration in tubby mouse by sulforaphane. Journal of Neurochemistry, 101(4), 1041–1052.
[25] Leung, L., et al. (2003). Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. Journal of Biological Chemistry, 278(48), 48021–48029.
[26] Lu, H., et al. (2010). Molecular and metabolic evidence for mitochondrial defects associated with β-cell dysfunction in a mouse model of type 2 diabetes. Diabetes, 59(2), 448–459.
[27] Lowry, O. H., et al. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
[28] Alrawaiq, N. S., Atia, A., & Abdullah, A. (2017). The effect of administration of an equal dose of different classes of dietary chemicals on NQO1 expressional level in mice liver. Pharmacophore, 8(5), 1–9.
[29] Abdullah, A., Alrawaiq, N. S., & Atia, A. (2018). Heme oxygenase 1 gene expression in mice liver is differently affected by equal doses of phytochemicals. Pharmacophore, 9(5), 13–17.
[30] Abdullah, A., Alrawaiq, N. S., & Atia, A. (2019). The effect of administration of an equal dose of different classes of phytochemicals on heme oxygenase-1 gene and protein expression in mice liver. Asian Journal of Pharmaceutical and Clinical Research, 12(3), 256–260.
[31] Matés, J. M., Pérez-Gómez, C., & De Castro, I. N. (1999). Antioxidant enzymes and human diseases. Clinical Biochemistry, 32(8), 595–603.
[32] Yang, Y. M., et al. (2010). Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants. Molecules, 15(9), 6332–6348.
[33] Byun, S., et al. (2012). Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis, 34(2), 397–405.
[34] Su, Z.-Y., et al. (2012). A perspective on dietary phytochemicals and cancer chemoprevention: Oxidative stress, Nrf2, and epigenomics. In Natural Products in Cancer Prevention and Therapy. Springer, pp. 133–162.
[35] Giudice, A., & Montella, M. (2006). Activation of the Nrf2–ARE signaling pathway: A promising strategy in cancer prevention. BioEssays, 28(2), 169–181.
[36] Lee, J.-S., & Surh, Y.-J. (2005). Nrf2 as a novel molecular target for chemoprevention. Cancer Letters, 224(2), 171–184.
[37] Liu, L., et al. (2018). Two sesquiterpene aminoquinones protect against oxidative injury in HaCaT keratinocytes via activation of AMPKα/ERK-Nrf2/ARE/HO-1 signaling. Biomedicine & Pharmacotherapy, 100, 417–425.
[38] Li, S., et al. (2018). Protective role of heme oxygenase-1 in fatty liver ischemia–reperfusion injury. Medical Molecular Morphology, 1–12.
[39] Hinds, T. D., Jr., et al. (2014). Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity, 22(3), 705–712.
[40] Durante, W. (2003). Heme oxygenase-1 in growth control and its clinical application to vascular disease. Journal of Cellular Physiology, 195(3), 373–382.
[41] Ji, L.-L., et al. (2015). The involvement of p62–Keap1–Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity. Free Radical Biology and Medicine, 85, 12–23.
[42] Weng, C.-J., et al. (2011). Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity. New Biotechnology, 28(6), 767–777.
[43] Domitrović, R., et al. (2012). Differential hepatoprotective mechanisms of rutin and quercetin in CCl₄-intoxicated BALB/cN mice. Acta Pharmacologica Sinica, 33(10), 1260.
[44] Ramyaa, P., & Padma, V. V. (2014). Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells—up regulation of Nrf2 expression and down regulation of NF-κB and COX-2. Biochimica et Biophysica Acta (BBA) – General Subjects, 1840(1), 681–692.
[45] Xie, Y.-L., et al. (2017). Curcumin attenuates lipopolysaccharide/D-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-κB activation. Biomedicine & Pharmacotherapy, 91, 70–77.
[46] Hajra, S., et al. (2018). Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation. Biomedicine & Pharmacotherapy, 101, 228–243.
[47] Liu, Y., et al. (2019). Sulforaphane attenuates HO-1-induced oxidant stress in human trabecular meshwork cells (HTMCs) via the phosphatidylinositol 3-kinase (PI3K)/serine/threonine kinase (Akt)-mediated factor-E2-related factor 2 (Nrf2) signaling activation. Medical Science Monitor, 25, 811–818.
[48] Keum, Y.-S., et al. (2006). Induction of heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes. Pharmaceutical Research, 23(11), 2586–2594.
[49] Luo, L., et al. (2015). Butylated hydroxyanisole induces distinct expression patterns of Nrf2 and detoxification enzymes in the liver and small intestine of C57BL/6 mice. Toxicology and Applied Pharmacology, 288(3), 339–348.
[50] McMahon, M., et al. (2001). The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Research, 61(8), 3299–307.
[51] Wild, A. C., Moinova, H. R., & Mulcahy, R. T. (1999). Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. Journal of Biological Chemistry, 274(47), 33627–36.
[52] Kwak, M. K., et al. (2001). Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1,2-dimethiole-3-thione. Molecular Medicine, 7(2), 135–45.
[53] Fahey, J. W., & Talalay, P. (1999). Antioxidant functions of sulforaphane: A potent inducer of phase II detoxication enzymes. Food and Chemical Toxicology, 37(9–10), 973–979.
[54] Hong, F., Freeman, M. L., & Liebler, D. C. (2005). Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chemical Research in Toxicology, 18(12), 1917–1926.
[55] Kansanen, E., et al. (2013). The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biology, 1(1), 45–49.
[56] Abiko, Y., et al. (2011). Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole. Toxicology and Applied Pharmacology, 255(1), 32–39.
[57] Dinkova-Kostova, A. T., & Wang, X. J. (2011). Induction of the Keap1/Nrf2/ARE pathway by oxidizable diphenols. Chemico-Biological Interactions, 192(1–2), 101–106.
[58] Surh, Y.-J. (2003). Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 3(10), 768.
[59] Hybertson, B. M., et al. (2011). Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine, 32(4–6), 234–246.
[60] Nguyen, T., Nioi, P., & Pickett, C. B. (2009). The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. Journal of Biological Chemistry, 284(20), 13291–13295.
[61] Sun, Z., Huang, Z., & Zhang, D. D. (2009). Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS ONE, 4(8), e6588.
[62] Numazawa, S., et al. (2003). Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. American Journal of Physiology – Cell Physiology, 285(2), C334–C342.
[63] Bloom, D. A., & Jaiswal, A. K. (2003). Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. Journal of Biological Chemistry, 278(45), 44675–44682.
[64] Chen, W., et al. (2009). Direct interaction between Nrf2 and p21Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response. Molecular Cell, 34(6), 663–673.
[65] Lau, A., et al. (2010). A noncanonical mechanism of Nrf2 activation by autophagy deficiency: Direct interaction between Keap1 and p62. Molecular and Cellular Biology, 30(13), 3275–3285.
[66] Bryan, H. K., et al. (2013). The Nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation. Biochemical Pharmacology, 85(6), 705–717.
Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
In a brief statement, the rights relate to the publication and distribution of research published in the journal of the University of Sebha where authors who have published their articles in the journal of the university of Sebha should how they can use or distribute their articles. They reserve all their rights to the published works, such as (but not limited to) the following rights:
- Copyright and other property rights related to the article, such as patent rights.
- Research published in the journal of the University of Sebha and used in its future works, including lectures and books, the right to reproduce articles for their own purposes, and the right to self-archive their articles.
- The right to enter a separate article, or for a non-exclusive distribution of their article with an acknowledgment of its initial publication in the journal of Sebha University.
Privacy Statement The names and e-mail addresses entered on the Sabha University Journal site will be used for the aforementioned purposes only and for which they were used.